NegGram Side Effects, Uses, Dosage, and Safety Info

Introduction

NegGram, also known by its generic name nalidixic acid, is a quinolone antibiotic used to treat urinary tract infections (UTIs) caused by susceptible gram-negative bacteria. As one of the first synthetic quinolone antibiotics, NegGram has played a significant role in the treatment of bacterial infections since its introduction in the 1960s.

Chemical Composition

NegGram‘s active ingredient, nalidixic acid, is a naphthyridine derivative with a chemical structure that allows it to inhibit bacterial DNA gyrase, an enzyme essential for DNA replication. This mechanism of action disrupts the synthesis of bacterial DNA, leading to the death of the bacteria.

Uses and Indications

NegGram is primarily indicated for the treatment of UTIs caused by susceptible gram-negative microorganisms, such as Escherichia coli, Enterobacter, and Klebsiella species. Its antibacterial activity makes it an effective option for managing these common infections of the urinary system.

Dosage Guidelines

The recommended dosage of NegGram varies depending on the severity of the infection and the patient’s age and weight. For adults, the usual dose is 1 gram taken orally four times daily for 7 to 14 days. Dosage adjustments may be necessary for patients with renal impairment or other special considerations. It is essential to follow the healthcare provider’s instructions and complete the entire course of treatment.

Side Effects

Like all medications, NegGram may cause side effects. Common side effects include nausea, vomiting, diarrhea, and abdominal pain. More serious side effects, such as allergic reactions, tendon rupture, or central nervous system disturbances, are rare but require immediate medical attention. Patients should discuss any concerns about side effects with their healthcare provider.

Clinical Studies and Efficacy

Numerous clinical studies have demonstrated NegGram‘s efficacy in treating UTIs. Bacteriologic and clinical assessments have shown high success rates in eradicating gram-negative pathogens and resolving symptoms. However, the emergence of quinolone-resistant bacteria has led to a decline in its use in recent years.

Pharmacokinetics and Pharmacodynamics

NegGram is rapidly absorbed from the gastrointestinal tract, with peak serum concentrations achieved within 1 to 2 hours after oral administration. It is primarily excreted unchanged in the urine, with a half-life of approximately 6 hours. NegGram‘s antibacterial action is concentration-dependent, meaning higher drug concentrations lead to greater bacterial killing.

Contraindications and Precautions

NegGram is contraindicated in patients with a known hypersensitivity to nalidixic acid or other quinolones. It should be used with caution in patients with a history of seizures, liver disease, or glucose-6-phosphate dehydrogenase (G6PD) deficiency. Pregnant and nursing women should consult their healthcare provider before using NegGram.

Drug Interactions

NegGram may interact with other medications, including antacids, iron supplements, and probenecid. These interactions can affect the absorption or elimination of NegGram, potentially altering its effectiveness or increasing the risk of side effects. Patients should inform their healthcare provider about all medications they are taking before starting treatment with NegGram.

Regulatory and Legal Status

NegGram has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of UTIs caused by susceptible gram-negative bacteria. The drug is available by prescription only and is supplied as oral caplets and an oral suspension. Healthcare providers should consult the FDA-approved package insert for complete prescribing information.

Patient Information

Patients taking NegGram should be advised to take the medication as directed, usually four times a day for the full duration of treatment. Skipping doses or stopping the medication early may lead to treatment failure or the development of antibiotic resistance. Patients should be aware of the potential side effects and report any severe or persistent symptoms to their healthcare provider. Drinking plenty of fluids and completing the entire course of treatment are essential for the successful management of UTIs with NegGram.